Amicus Therapeutics (FOLD) Payables (2016 - 2025)
Historic Payables for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $19.1 million.
- Amicus Therapeutics' Payables rose 4170.31% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.1 million, marking a year-over-year increase of 4170.31%. This contributed to the annual value of $12.9 million for FY2024, which is 1437.17% down from last year.
- Per Amicus Therapeutics' latest filing, its Payables stood at $19.1 million for Q3 2025, which was up 4170.31% from $13.9 million recorded in Q2 2025.
- Amicus Therapeutics' Payables' 5-year high stood at $32.1 million during Q2 2024, with a 5-year trough of $9.2 million in Q1 2024.
- In the last 5 years, Amicus Therapeutics' Payables had a median value of $15.4 million in 2022 and averaged $18.0 million.
- Examining YoY changes over the last 5 years, Amicus Therapeutics' Payables showed a top increase of 13707.29% in 2024 and a maximum decrease of 6310.84% in 2024.
- Amicus Therapeutics' Payables (Quarter) stood at $21.5 million in 2021, then fell by 28.35% to $15.4 million in 2022, then fell by 1.9% to $15.1 million in 2023, then fell by 14.37% to $12.9 million in 2024, then soared by 47.55% to $19.1 million in 2025.
- Its Payables stands at $19.1 million for Q3 2025, versus $13.9 million for Q2 2025 and $14.5 million for Q1 2025.